Safety and efficacy of daratumumab with lenalidomide and dexamethasone in relapsed or relapsed, refractory multiple myeloma.
Torben Plesner
Employment or Leadership Position - Celgene; Janssen Pharmaceutical
Consultant or Advisory Role - Genmab
Hendrik-Tobias Arkenau
No relevant relationships to disclose
Henk M. Lokhorst
Consultant or Advisory Role - Genmab
Honoraria - Celgene; Janssen-Cilag; Mundipharma
Research Funding - Genmab
Peter Gimsing
No relevant relationships to disclose
Jakub Krejcik
No relevant relationships to disclose
Charlotte Rose Lemech
No relevant relationships to disclose
Monique Minnema
Consultant or Advisory Role - Janssen-Cilag
Honoraria - Janssen-Cilag
Ulrik Niels Lassen
No relevant relationships to disclose
Tahamtan Ahmadi
Employment or Leadership Position - Janssen Research & Development
Howard Yeh
Employment or Leadership Position - Janssen Research & Development
Mary Guckert
Employment or Leadership Position - Janssen Research & Development
Nikolai C. Brun
Employment or Leadership Position - Genmab
Steen Lisby
Employment or Leadership Position - Genmab
Stock Ownership - Genmab
Linda Basse
Employment or Leadership Position - Genmab
Antonio Palumbo
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Pharmaceutical ; Onyx
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen Pharmaceutical ; Onyx
Paul G. Richardson
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Johnson & Johnson; Millennium; Novartis